You just read:

Entest BioMedical's Subsidiary Zander Therapeutics, Inc. Reports on Preliminary Canine Experiments Testing New Anti-Inflammatory Drug Compounds

News provided by

Entest BioMedical Inc.

Jun 07, 2017, 08:00 ET